UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Leukemia, 2016-02, Vol.30 (2), p.423-430

2016

Volltextzugriff (PDF)

Effects of long-term nitrogen addition on phosphorus cycling in organic soil horizons of temperate forests

Biogeochemistry, 2018-11, Vol.141 (2), p.167-181

2018

Volltextzugriff (PDF)

Inhibiting MEK in MAPK pathway-activated myeloma

Leukemia, 2016-04, Vol.30 (4), p.976-980

2016

Volltextzugriff (PDF)

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Leukemia, 2012-11, Vol.26 (11), p.2398-2405

2012

Volltextzugriff (PDF)

Serial exome analysis of disease progression in premalignant gammopathies

Leukemia, 2014-07, Vol.28 (7), p.1548-1552

2014

Volltextzugriff (PDF)

Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia

Leukemia, 2014-04, Vol.28 (4), p.888-893

2014

Volltextzugriff (PDF)

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

Leukemia, 2014-12, Vol.28 (12), p.2410-2413

2014

Volltextzugriff (PDF)

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma

Leukemia, 2015-12, Vol.29 (12), p.2418-2421

2015

Volltextzugriff (PDF)

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL‐1)

HemaSphere, 2023-05, Vol.7 (S2), p.26-27

2023

Volltextzugriff (PDF)

AB1194 Serum cartilage oligomeric matrix protein compared to articular cartilage thickness in children with juvenile idiopathic arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.706-706

2013

Volltextzugriff (PDF)

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

Leukemia, 2015-08, Vol.29 (8), p.1713-1720

2015

Volltextzugriff (PDF)

OP0012 Chronic recurrent non-bacterial osteomyelitis in danish children

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.56-56

2013

Volltextzugriff (PDF)

S170: DYNAMIC INTERPLAY BETWEEN TUMOR AND MICRO‐ENVIRONMENT DURING MYELOMA DISEASE PROGRESSION

HemaSphere, 2022-06, Vol.6, p.71-72

2022

Volltextzugriff (PDF)

A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide

Archives of disease in childhood, 2000-10, Vol.83 (4), p.334-339

2000

Volltextzugriff (PDF)

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Journal of cancer research and clinical oncology, 2021-02, Vol.147 (2), p.619-631

2021

Volltextzugriff (PDF)

Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids

Allergy (Copenhagen), 2004-11, Vol.59 (11), p.1193-1197

2004

Volltextzugriff (PDF)

Circadian variations in serum eosinophil cationic protein, and serum and urine eosinophil protein X

Pediatric allergy and immunology, 2003-04, Vol.14 (2), p.130-133

2003

Volltextzugriff (PDF)

Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients

Journal of clinical pharmacology, 2021-05, Vol.61 (5), p.614-627

2021

Volltextzugriff (PDF)

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

Annals of hematology, 2021-04, Vol.100 (4), p.1065-1077

2021

Volltextzugriff (PDF)

The Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine, 25-26 April 1999

Scandinavian journal of clinical and laboratory investigation, 1999, Vol.59 (7), p.475-475

Anders Kallner, Matthew McQueen, Claus Heuck

1999

Volltextzugriff (PDF)

Diurnal variations in serum and urine markers of type I and type III collagen turnover in children

Clinical chemistry (Baltimore, Md.), 2001-09, Vol.47 (9), p.1721-1722

2001

Volltextzugriff (PDF)

Correction to: Organic phosphorus in the terrestrial environment: a perspective on the state of the art and future priorities

Plant and soil, 2018-06, Vol.427 (1-2), p.209-211

2018

Volltextzugriff (PDF)

Induction, binding specificity and function of human ICOS

European journal of immunology, 2000-12, Vol.30 (12), p.3707-3717

2000

Volltextzugriff (PDF)

Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand

European journal of immunology, 2000-04, Vol.30 (4), p.1040-1047

2000

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(89)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Effects of long-term nitrogen addition on phosphorus cycling in organic soil horizons of temperate forests

Inhibiting MEK in MAPK pathway-activated myeloma

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Serial exome analysis of disease progression in premalignant gammopathies

Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma

P29 PHASE 1/2 RESULTS OF TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) (MONUMENTAL‐1)

AB1194 Serum cartilage oligomeric matrix protein compared to articular cartilage thickness in children with juvenile idiopathic arthritis

P42 HEALTH‐RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED WITH TALQUETAMAB, A G PROTEIN‐COUPLED RECEPTOR FAMILY C GROUP 5 MEMBER D X CD3 BISPECIFIC ANTIBODY, FROM MONUMENTAL‐1

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

OP0012 Chronic recurrent non-bacterial osteomyelitis in danish children

S170: DYNAMIC INTERPLAY BETWEEN TUMOR AND MICRO‐ENVIRONMENT DURING MYELOMA DISEASE PROGRESSION

A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results

Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids

Circadian variations in serum eosinophil cationic protein, and serum and urine eosinophil protein X

Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients

Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study

The Stockholm Consensus Conference on Quality Specifications in Laboratory Medicine, 25-26 April 1999

Diurnal variations in serum and urine markers of type I and type III collagen turnover in children

Correction to: Organic phosphorus in the terrestrial environment: a perspective on the state of the art and future priorities

Induction, binding specificity and function of human ICOS

Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand

Aktive Filter

Suchergebnisse filtern